How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

723 results for

Cardiovascular rehabilitation

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes Full Text available with Trip Pro

of the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Prev Cardiol . 2016 ; 23 : 657–667 We acknowledge that our scope neglects younger, less competitive, or older athletes who collectively represent a population in which a much larger number of CV events can occur. x 6 Maron, B.J., Estes, N.A. III, and Maron, M.S. Is it fair to screen only competitive athletes for sudden death risk, or is it time to level the playing field?. Am J Cardiol . 2018 ; 121 : 1008–1010 “Red flags (...) Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes - Canadian Journal of Cardiology Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 35, Issue 1, Pages 1–11 Canadian Cardiovascular Society/Canadian

2018 Canadian Cardiovascular Society

22. The Management of Upper Extremity Amputation Rehabilitation (UEAR)

(ADL) and instrumental activities of daily living (IADL) training with and without a prosthesis, physical conditioning, and psychosocial rehabilitation to maximize the patient’s function and quality of life • Describe appropriate interventions to optimize the patient’s physical function after an amputation (e.g., range of motion, flexibility, muscle strength and endurance, and cardiovascular fitness) • Develop clinical pathways that are consistent with current evidence-based rehabilitation methods (...) The Management of Upper Extremity Amputation Rehabilitation (UEAR) VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF UPPER EXTREMITY AMPUTATION REHABILITATION Department of Veterans Affairs Department of Defense QUALIFYING STATEMENTS The Department of Veterans Affairs and the Department of Defense guidelines are based upon the best information available at the time of publication. They are designed to provide information and assist decision making. They are not intended to define

2014 VA/DoD Clinical Practice Guidelines

23. Heart Failure Guidelines 2013 Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization

Heart Failure Guidelines 2013 Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization - Canadian Journal of Cardiology Email/Username: Password: Remember me Search Terms Search within Search Share this page Volume 30, Issue 3, Pages 249–263 The 2013 Canadian Cardiovascular Society Heart Failure Management (...) imaging evidence of extensive cardiac ischemia, PCI might be considered. AVR, aortic valve replacement; CABG, coronary artery bypass grafting; IC, intracoronary; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention. Abstract The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update provides focused discussions on the management recommendations on 2 topics: (1) exercise and rehabilitation; and (2) surgical coronary revascularization in patients

2013 Canadian Cardiovascular Society

24. 2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease Full Text available with Trip Pro

DBP Diastolic blood pressure DCM Dilated cardiomyopathy EACPR European Association for Cardiovascular Prevention and Rehabilitation EAPC European Association of Preventive Cardiology ECV Extracellular volume ECG Electrocardiogram EDS Ehlers Danlos syndrome EF Ejection fraction EP Electrophysiological ESC European Society of Cardiology Ex-R Exercise-related exCR Exercise-based cardiac rehabilitation FFR Fractional flow reserve FITT Frequency, intensity, time, and type HCM Hypertrophic (...) 2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Navbar Search Filter Mobile Microsite Search Term search filter search input Article

2020 European Society of Cardiology

25. CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic

CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic 10.1161/CIRCULATIONAHA.120.047011 1 CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic Running Title: Han et al.; Consensus on Managing CVD during COVID-19 Epidemic Yaling Han, MD, FACC, FAHA, Chair 1 ; Hesong Zeng, MD, co-chair 2 ; Hong Jiang, MD, FACC, co (...) the Chinese Medical Association (CMA). Sole responsibility of the translation rests with the Chinese Medical Association. This translation, Copyright ©2020 by the Chinese Medical Association (CMA). The original article entitled “Expert consensus on principal of clinical management of patients with severe emergent cardiovascular diseases during the epidemic period of COVID-19” [DOI: 10.3760/cma.j.cn112148-20200210-00066 Copyright ©2020] was prepared by (Yaling Han, MD, Department of Cardiology, General

2020 Covid-19 Ad hoc guidelines

26. Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary Prevention Programs: 2012 Update Full Text available with Trip Pro

2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary Prevention Programs: 2012 Update A Statement for Health Care Professionals From the American Association of Cardiovascular and Pulmonary Rehabilitation and the American Heart Association , MD , MD, MSPH , MD , RN, MS , and MD, MS PhDFrom Helen Hayes Hospital (...) in the roles, responsibilities, and engagement of CR/SP medical directors. Since the publication of the 2005 scientific statement from the American Heart Association and American Association of Cardiovascular and Pulmonary Rehabilitation regarding medical director responsibilities for outpatient CR/SP programs, significant changes have occurred. This statement updates the responsibilities of CR/SP medical directors, in view of changes in federal legislation and regulations and changes in health care

2012 American Heart Association

27. Increasing Referral and Participation Rates to Outpatient Cardiac Rehabilitation: The Valuable Role of Healthcare Professionals in the Inpatient and Home Health Settings Full Text available with Trip Pro

With Heart Failure Questionnaire. * The functional assessment, submaximal exercise test, and inpatient CR program should use all methods outlined in the American Association of Cardiovascular and Pulmonary Rehabilitation cardiac rehabilitation guidelines, including monitoring of symptoms, vital signs, and ECG in appropriate patients, as well as American Association of Cardiovascular and Pulmonary Rehabilitation/American College of Cardiology/American Heart Association performance measures for cardiac (...) members should understand completely, particularly the inpatient CR director, are the “AACVPR/ACCF/AHA 2010 Update: Performance Measures on Cardiac Rehabilitation for Referral to Cardiac Rehabilitation/Secondary Prevention Services: A Report of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Clinical Performance Measures for Cardiac

2012 American Heart Association

28. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance Full Text available with Trip Pro

Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance - Canadian Journal of Cardiology Go search , P357-372, March 01, 2020 Powered By Mendeley Share on Canadian Cardiovascular Society Position Statement on Postural Orthostatic (...) Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance Satish R. Raj Correspondence Corresponding author: Dr Satish R. Raj, GAC70 HRIC Building, University of Calgary, 3280 Hospital Dr NW, Calgary, Alberta T2N 4Z6, Canada. Tel.: +1-403-210-6152; fax: +1-403-210-9444. Affiliations Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada Juan C. Guzman Affiliations Department of Medicine, McMaster University

2020 Canadian Cardiovascular Society

29. 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult Society Guidelines 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult Todd J. Anderson, MD, a, * Jean Gr egoire, MD, b, * Glen J. Pearson, PharmD, c, * Arden R. Barry, PharmD, d Patrick Couture, MD, e Martin Dawes, MD, f Gordon A. Francis, MD, g Jacques Genest, Jr, MD (...) , h Steven Grover, MD, i Milan Gupta, MD, j,k Robert A. Hegele, MD, l David C. Lau, MD, PhD, m Lawrence A. Leiter, MD, k Eva Lonn, MD, n G.B. John Mancini, MD, f Ruth McPherson, MD, PhD, o Daniel Ngui, MD, f Paul Poirier, MD, PhD, p John L. Sievenpiper, MD, PhD, k James A. Stone, MD, PhD, a George Thanassoulis, MD, h and Richard Ward, MD q a Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; b Institut de Cardiologie de Montr eal, Universit

2016 CPG Infobase

30. Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD Full Text available with Trip Pro

Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Search Account Menu Menu Navbar Search Filter (...) Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article Navigation Article Contents Article Navigation 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) Francesco Cosentino ESC Chairperson Sweden

2019 European Society of Cardiology

31. The Management of Dyslipidemia for Cardiovascular Risk Reduction

, exercise-based cardiac rehabilitation program for patients with recent occurrence of coronary heart disease (i.e., myocardial infarction, diagnosis of coronary artery disease, coronary artery bypass grafting, or percutaneous coronary intervention) to reduce cardiovascular morbidity and mortality. Strong for Reviewed, New- added a For additional information, see Grading Recommendations. b For additional information, see Recommendation Categorization and Appendix G. * Statin doses listed as “moderate (...) The Management of Dyslipidemia for Cardiovascular Risk Reduction VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF DYSLIPIDEMIA FOR CARDIOVASCULAR RISK REDUCTION Department of Veterans Affairs Department of Defense QUALIFYING STATEMENTS The Department of Veterans Affairs and the Department of Defense guidelines are based upon the best information available at the time of publication. They are designed to provide information and assist decision making. They are not intended to define

2020 VA/DoD Clinical Practice Guidelines

32. Cardiovascular disease and COVID-19: Australian/New Zealand consensus statement

Cardiovascular disease and COVID-19: Australian/New Zealand consensus statement Cardiovascular disease and COVID-19: Australian/New Zealand consensus statement | The Medical Journal of Australia search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login Purchase options Connect person_outline Login keyboard_arrow_down Individual Login Purchase (...) options menu search Article types Advertisement close Cardiovascular disease and COVID-19: Australian/New Zealand consensus statement Sarah Zaman, Andrew I MacIsaac, Garry LR Jennings, Markus Schlaich, Sally C Inglis, Ruth Arnold, Derek P Chew, Saurabh Kumar, Liza Thomas, Sudhir Wahi, Stephen J Duffy, Sidney Lo, Andrew Newcomb, Aubrey Almeida, Carolyn Naismith, Mayanna Lund, Stephen J Nicholls, Selwyn Wong, Leonard Kritharides, Clara K Chow and Ravinay Bhindi Med J Aust Published online: 3 April 2020

2020 Cardiac Society of Australia and New Zealand

33. Key Questions on COVID-19 and Cardiovascular Disease

with hypertension, available . What is home-based cardiac rehabilitation and how could it be used during COVID-19? Category: CV Therapeutics Patient Type: COVID- CV Prevalence: COMMON Principal Guidance: Home-based cardiac rehab has demonstrated comparable benefits to traditional hospital-based programs and may serve as a viable alternative during COVID-19; reimbursement, unfortunately, remains limited. Author: Ty J. Gluckman, MD, FACC; Pam R. Taub, MD, FACC, FASPC Source: SQC Approval Date: May 11, 2020 (...) and modifiable cardiovascular risk factor improvement, including blood pressure and LDL-C control. A recent AACVPR/AHA/ACC Scientific Statement on HBCR concluded that HBCR may be a reasonable option for clinically stable, low-to-moderate risk patients unable to attend conventional cardiac rehab, available . The AACVPR has identified a number of viable options for HBCR, ranging from standalone apps to device-integrated programs that can monitor blood pressure, ECG and other physiological data, available

2020 American College of Cardiology

34. Cardiovascular Disease: Secondary Prevention

) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016 Oct;253:281-344. Downs JR, O'Malley PG. Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline. Ann Intern Med. 2015 Aug 18;163(4):291-297. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention (...) societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016 Sep; 252:207-274. Sabatine MS, Giugliano RP, Keech AC, et al for the FOURIER Steering Committee and Investigators. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med. 2017 May 4;376(18):1713-1722. Stone NJ, Robinson JG, Lichtenstein AH, et al for the American College of Cardiology/American

2018 Kaiser Permanente Clinical Guidelines

35. Cardiovascular Disease: Primary Prevention

of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016 Oct; 253:281- 344. Chou R, Dana T, Blazina I, et al. Statin Use for the Prevention of Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Nov. Report No. 14-05206-EF-2. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Cziraky MJ, Willey VJ (...) by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016 Sep; 252:207-274. Pursnani A, Massaro JM, D'Agostino RB Sr, O'Donnell CJ, Hoffmann U. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events. JAMA. 2015 Jul 14;314(2):134-141. Richardson K, Schoen M, French B, et al. Statins and cognitive function: a systematic review. Ann

2018 Kaiser Permanente Clinical Guidelines

36. Primary Prevention of Cardiovascular Disease

of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Geriatrics Society, the American Society of Preventive Cardiology, and the Preventive Cardiovascular Nurses Association WRITING COMMITTEE MEMBERS Donna K. Arnett, PhD, MSPH, FAHA, Co-Chair Roger S. Blumenthal, MD, FACC, FAHA, Co-Chair Michelle A. Albert, MD, MPH, FAHA* Erin D. Michos, MD, MHS, FACC, FAHA* Andrew B. Buroker, Esq (...) Primary Prevention of Cardiovascular Disease Accepted Manuscript 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease WRITING COMMITTEE MEMBERS, Donna K. Arnett, PhD, MSPH, FAHA, Co-Chair, Roger S. Blumenthal, MD, FACC, FAHA, Co-Chair, Michelle A. Albert, MD, MPH, FAHA, Erin D. Michos, MD, MHS, FACC, FAHA, Andrew B. Buroker, Esq, Michael D. Miedema, MD, MPH, Zachary D. Goldberger, MD, MS, FACC, FAHA, Daniel Muñoz, MD, MPA, FACC, Ellen J. Hahn, PhD, RN, Sidney C. Smith, Jr

2019 American College of Cardiology

37. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association

Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search December 2019 November 2019 October 2019 September 2019 August 2019 July 2019 June 2019 May (...) 2019 April 2019 March 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association , MD, MSc, FAHA, Chair , MD, Vice Chair , PhD , MD, MPH, FAHA , MD , MD, MSc , MD , MS , MD, FAHA , MD, MS Matthew J. Feinstein

2019 American Heart Association

38. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease Arnett et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease Page 1 of 98 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Geriatrics Society, the American (...) http://ahajournals.org by on April 25, 2019Arnett et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease Page 8 of 98 1.3. Document Review and Approval This document was reviewed by 5 official reviewers nominated by the ACC and AHA (1 reviewer from the ACC/AHA Task Force for Practice Guidelines, 2 reviewers from the AHA, and 2 reviewers from the ACC); 3 reviewers on behalf of the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Society

2019 American Heart Association

39. Cardiovascular Disease Risk

atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S46-8. 3. Tobe SW, Stone JA, Brouweres M, Bhattacharyya O, Walker KM, Dawes M, et al. Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE initiative. CMAJ. 2011;183(15):E1135-50. 4. European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z (...) Cardiovascular Disease Risk PEER SIMPLIFIED GUIDELINE: PREVENTION AND MANAGEMENT OF CARDIOVASCULAR DISEASE RISK IN PRIMARY CARE Clinical Practice Guideline | February 2015 These recommendations are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances. They should be used as an adjunct to sound clinical decision making. OBJECTIVE Alberta primary care clinicians and their teams offer primary

2019 Accelerating Change Transformation Team

40. Risk estimation and the prevention of cardiovascular disease

recommendations for the management of people with chronic heart failure, acute coronary syndrome, stable angina or cardiac arrhythmias as these are contained within other SIGN guidelines. 13-16 Cardiac rehabilitation is the subject of a further SIGN guideline. 17 1.2.2 TARGET USERS OF THE GUIDELINE This guideline will be of interest to healthcare professionals involved in the management of patients with cardiovascular disease including cardiologists, dietitians, general practitioners, lipidologists (...) Risk estimation and the prevention of cardiovascular disease SIGN 149 • Risk estimation and the prevention of cardiovascular disease A national clinical guideline June 2017 Evidencewww.healthcareimprovementscotland.org Edinburgh Office | Gyle Square |1 South Gyle Crescent | Edinburgh | EH12 9EB Telephone 0131 623 4300 Fax 0131 623 4299 Glasgow Office | Delta House | 50 West Nile Street | Glasgow | G1 2NP Telephone 0141 225 6999 Fax 0141 248 3776 The Healthcare Environment Inspectorate

2017 SIGN

Guidelines

Guidelines – filter by country